Archives for April 20, 2005

← 2005

EGA questions European moves on drug patents

The European Generic Medicines Association has criticised proposals by the European Commission to offer six months' additional patent protection to companies conducting trials of their drug products in children.

Foot and mouth peptide improves antibody production

Scientists at US biotechnology firm Cell Genesys have developed a gene expression technology that could improve the commercial production of monoclonal antibodies and other complex therapeutic proteins, reports Phil Taylor.

Disposables 'could cut vaccine development time'

The use of disposable and scalable technologies to purify large molecule vectors can help manufacturers streamline processes and overcome many of the unique challenges associated with vaccine development, according to separations specialist Pall.

June launch for Corona CAD in Europe

ESA will officially launch its universal detector for use with high performance liquid chromatography (HPLC), based on a technology called CAD (charged aserosol detector), in Europe at the HPLC 2005 exhibition in Stockholm in June.

Xceleron gives FDA document thumbs up

Xceleron has given the FDA its seal of approval after the regulatory body drafted a guidance document that favoured a more flexible experimental approach to early Phase I clinical studies.

LION to sell bioinformatics business

German informatics firm LION bioscience is to sell its bioinformatics business, in a move that reflects its ongoing restructuring plans that has previously seen an employee cut of at least 50 per cent.

Lanxess plans expansion into Japan

The fine chemicals business unit of Lanxess, which was spun-out from Germany's Bayer earlier this year and provides custom manufacturing services to the pharmaceutical and other industries, has said it plans to expand its geographic focus into the...

India enjoys increased drug R&D opportunities

According to a new report, the Indian drug sector is evolving rapidly, creating opportunities both domestic and globally. However, how Indian drug companies mould their strategies in the face of product patent protection will determine future growth.

Agilent introduces 3X faster scan cycle spectrometer

Agilent Technologies introduces a high-performance ion trap mass spectrometer (MS) that allows the identification of 60-80 per cent more peptides than preceding models in proteomic applications. The spectrometer will lead to a better understanding of...